Sorafenib in locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: a randomized, double-blind, phase 3 trial

BACKGROUND: Patients with radioactive iodine ((131)I, RAI)-refractory locally advanced or metastatic differentiated thyroid cancer (DTC) have a poor prognosis due to the lack of effective treatment options. METHODS: This multicentre, randomized (1:1), double-blind, placebo-controlled, phase 3 study...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Lancet
Egile Nagusiak: Brose, Marcia S, Nutting, Christopher M, Jarzab, Barbara, Elisei, Rossella, Siena, Salvatore, Bastholt, Lars, de la Fouchardiere, Christelle, Pacini, Furio, Paschke, Ralf, KeeShong, Young, Sherman, Steven I, Smit, Johannes WA, Chung, John, Kappeler, Christian, Pena, Carol, Molnár, István, Schlumberger, Martin J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366116/
https://ncbi.nlm.nih.gov/pubmed/24768112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(14)60421-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak